Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Phase II Brentuximab Vedotin and Lenalidomide in Relapsed/Refractory T-Cell Lymphomas

Protocol: OSU-17204

Full Title

A Phase II Study of Brentuximab Vedotin and Lenalidomide in Relapsed and Refractory T-Cell Lymphomas

Lymphoma Non-Hodgkin’s Lymphoma (B- & T-Cell) Cutaneous Lymphoma